ClinicalTrials.Veeva

Menu

viTAmin K2 and rEcOVery From ExeRcise (TAKEOVER)

U

University of Glasgow

Status

Completed

Conditions

Inflammation
Vitamin K
Strength
Oxidative Stress
Recovery
Exercise

Treatments

Dietary Supplement: Vitamin K2
Dietary Supplement: Micro-crystalline cellulose

Study type

Interventional

Funder types

Other

Identifiers

NCT04676958
200190189

Details and patient eligibility

About

The aim of the current study, therefore, is to investigate the effects of vitamin K2 supplementation on the physiological responses to an acute bout of resistance exercise.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participant is able and willing to sign the Informed Consent From
  • No plans to change lifestyle (activity and nutrition) during the study period
  • Older group (n=40): 65 years of age or older.
  • Younger group (n=40): Aged 18-40 years

Exclusion criteria

  • Not currently, or in the last year, participating in more than 1h per week of vigorous aerobic physical activity or any resistance exercise
  • BMI > 30 kg/m2
  • diabetes
  • severe cardiovascular disease
  • seizure disorders
  • liver disease
  • uncontrolled hypertension (>150/90mmHg at baseline measurement)
  • cancer or cancer that has been in remission <5 years
  • ambulatory impairments which would limit ability to perform assessments of muscle function
  • dementia
  • currently taking Vitamin K2 supplements
  • currently taking Vitamin K antagonists/anticoagulants (e.g. warfarin)
  • current smoking
  • history of drug abuse
  • taking medication known to affect muscle (e.g. steroids).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
380 mg capsule/day micro-crystalline cellulose
Treatment:
Dietary Supplement: Micro-crystalline cellulose
Vitamin K2
Active Comparator group
Description:
380 mg capsule/day micro-crystalline cellulose including 240ug/day Vitamin K2
Treatment:
Dietary Supplement: Vitamin K2

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems